Autoimmune Liver Disease: Basic and Clinical Aspects

Author: Qiu Dekai
Publisher:
Publish Date: 2006-01-01
Features: This book is part of the "Huaxia Talent Fund Academic Series." It provides a comprehensive and in-depth discussion on the clinical manifestations, pathogenesis, and treatment strategies of autoimmune liver diseases, making it a specialized work on autoimmune liver diseases in China. It is suitable for internists, especially those specializing in gastroenterology and hepatology, as well as clinical researchers and graduate students for reference. Autoimmune liver diseases are a group of chronic liver and biliary diseases mediated by autoimmunity, primarily including autoimmune hepatitis, primary biliary cirrhosis, primary sclerosing cholangitis, and their overlapping syndromes. However, the understanding of autoimmune liver diseases in China is still insufficient, often only briefly mentioned in general gastroenterology or hepatology textbooks, with no dedicated works on the subject yet available, which far fails to meet the current needs of clinical and research practices. With increasing awareness and advancements in diagnostic techniques, the incidence of these diseases is on the rise. Research on the diagnosis and treatment of autoimmune liver diseases has garnered growing attention from scholars in China. This book is authored by a team of highly experienced experts and professors. Professor Qiu Dekai and his colleagues are involved in high-level research projects such as the National Natural Science Foundation of China and possess extensive clinical experience. They have published several authoritative works and numerous research and clinical papers, demonstrating a high academic standard. The book provides a comprehensive, systematic, and in-depth exploration of the clinical manifestations, pathogenesis, genetic susceptibility, treatment, and autoimmune manifestations in other liver diseases, serving as a valuable reference for clinical and research professionals. It plays a positive role in guiding the diagnosis and treatment of autoimmune liver diseases, thereby generating certain economic and social impact.